Skip to Main Content

Christopher D. Sheaffer

Partner, Private Equity

christophersheaffer@paulhastings.com

Christopher D. Sheaffer is a partner in the Private Equity and M&A practices at Paul Hastings and is chair of the Chicago office. His practice is focused on representing private equity firms in leveraged buyouts, minority investments, add-on acquisitions, divestitures and recapitalizations. He is a trusted leader for clients investing in a wide range of transaction sizes and sectors, including Cortec Group (over 20 transactions), Wynnchurch Capital (over 20 transactions), BPOC (over 20 transactions), Pfingsten Partners (over 40 transactions), May River Capital and Five Arrows Capital Partners. Chris also regularly represents public companies, closely-held businesses, entrepreneurs and senior management teams in connection with mergers and acquisitions and financing transactions.

REPRESENTATIONS de

  • Represented BPOC in over 20 transactions, including: Its sale of Maxor National Pharmacy Services Its acquisition of Praxis Its acquisition of Bridgeway Its sale of Maverick Healthcare Its acquisition of Zenith American Solutions Its sale of Medical Solutions Its acquisition of Spectrum Professional Services Its sale of RSA Medical Its acquisition of Medical Solutions Its acquisition of himagine solutions

  • Its sale of Maxor National Pharmacy Services

RECOGNITION de

  • Recognized, Notable practitioner

    IFLR1000

  • Top ranked lawyer for Private Equity: Buyouts

    Chambers USA - Nationwide

PAST ENGAGEMENTS de

  • “Alternatives for Portfolio Company Structures in Private Equity Transactions,” Bloomberg BNA webinar
    FEBRUARY 21, 2013
  • Investment Bank Engagement Letter Study, Paul Hastings 2013-14)